GVK BIO Sign An Agreement With Product Development Companies

GVK Biosciences (GVK BIO), Asia discovery of advanced drug research and development organization announced today that it has been selected as preferred supplier to a consortium of 14 partners in product development around the world (PDP) for Clinical Services Asia. GVK BIO is the only member who is based in India.

The DPP is funded in part by the Bill and Melinda Gates Foundation is not-for-profit enterprises focused on developing new interventions for diseases that are often neglected by the pharmaceutical industry and public biotechnology companies such as tuberculosis, malaria, kala-azar, HIV / AIDS, childhood pneumonia, and diarrhea. Total 14 PDP plans to fund 85 clinical trials in developing countries over the next two years and the functions of central India as a country in development.

GVK BIO currently working with some of the PDP and to cooperate with investigators and public institutions in India and Bangladesh to help develop preventive and therapeutic modalities that can potentially be introduced into public health programs to significantly reduce social and economic burden of these diseases. GVK BIO will work with the consortium as a provider of specialized services for clinical monitoring, security and logistical support beyond the control of the overall project management.

"Gvk Biosciences is pleased to support solutions for health care for neglected infectious diseases in India. We are excited to partner with PDP in promoting its clinical programs and to help solve medical problems and health for millions around the world," Manni said Kantipudi, Managing Director, Gvk Biosciences.